Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q24234065)
Watch
English
Nicotine receptor partial agonists for smoking cessation
scientific article (published 2011-02-16)
In more languages
edit
Statements
instance of
scholarly article
0 references
meta-analysis
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Nicotine receptor partial agonists for smoking cessation
(English)
0 references
main subject
smoking
1 reference
based on heuristic
inferred from title
nicotine
0 references
author name string
Kate Cahill
series ordinal
1
0 references
Lindsay F Stead
series ordinal
2
0 references
Tim Lancaster
series ordinal
3
0 references
publication date
16 February 2011
0 references
published in
Cochrane Database of Systematic Reviews
0 references
cites work
Cytisine for smoking cessation: a literature review and a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Scope and impact of financial conflicts of interest in biomedical research: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antidepressants for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicotine replacement therapy for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Telephone counselling for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicotine receptor partial agonists for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicotine receptor partial agonists for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline as maintenance therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Behavioral counseling and varenicline treatment for smoking cessation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of varenicline for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytisine for smoking cessation: a research agenda
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicotine addiction.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of knock-out mice to determine the molecular basis for the actions of nicotine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measures of abstinence in clinical trials: issues and recommendations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline and bupropion sustained-release combination therapy for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination treatment with varenicline and nicotine replacement therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome criteria in smoking cessation trials: proposal for a common standard.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Smoking-cessation therapy using varenicline: the cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline for smoking cessation: a placebo-controlled, randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A longer course of varenicline therapy improves smoking cessation rates.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measuring inconsistency in meta-analyses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An uncontrolled trial of cytisine (Tabex) for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The place of varenicline in smoking cessation treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline for smoking cessation in patients with coronary heart disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comment and reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Smoking is a disease and smokers are patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: new treatment with efficacy in smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neuropharmacology and potential efficacy of new treatments for tobacco dependence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: progress in smoking cessation treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Advances in pharmacotherapy for tobacco dependence.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A preliminary benefit-risk assessment of varenicline in smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: a novel pharmacotherapy for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: a review of its use as an aid to smoking cessation therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/14651858.CD006103.PUB5
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
518190
OpenCitations bibliographic resource ID
518190
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
518190
PubMed publication ID
21328282
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
518190
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
